In recent years, major scientific advances have created new treatment paradigms and new hope for lung cancer patients. Here are the most notable examples:

1. Tracking changes

New research continues to evolve our understanding of non-small cell lung cancer (NSCLC) from a single entity to a disease comprised of genetically and clinically distinct subgroups.

2. Spotting subtypes

The identification and treatment of molecular subtypes of lung cancer has had a profound impact on patient outcomes.

3. Immunotherapy

Activation of the immune system to treat lung cancer has demonstrated incredible success and very encouraging life expectancy for many lung cancer patients.

4. Screening effectively

Early detection of lung cancer with low dose computed tomography (LDCT) screening of patients with a smoking history and age 55 to 74 is a proven method of reducing mortality.

5. Precise cuts

The role of surgery remains important in the management of early and locally advanced lung cancer. Ongoing research will refine screening algorithms and the role of surgery in screen-detected nodules.

6. Aiming higher

Today, patients with large tumors and lymph node-positive NSCLC receive cisplatin-based adjuvant chemotherapy is as the standard of care, for patients with large tumors and lymph node-positive NSCLC, and resultsresulting in an absolute improvement in the five-year survival rate of approximately 5 percent to 15 percent. The next generation of clinical trials in the adjuvant setting will include integration of targeted therapy and immunotherapy.

7. Creating grounds for testing

The costs of recently-approved drugs for lung cancer heightens the importance of considering value in treatment decisions, and has placed lung cancer at the center of emerging and evolving paradigms of care delivery.